RCUS – Arcus Biosciences Inc
Investors holding1
Combined shares131,221
Combined reported value$3.4M
RCUS chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.
Ownership
| Investor | % of their portfolio | Change | Shares | Reported value | Period |
|---|---|---|---|---|---|
| Paul Tudor Jones narrow view | 0.02 | New | 131,221 | $3.4M | Q3 2026 |
Activity: last 4 quarters
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Paul Tudor Jones narrow view | New | 131,221 | 0.02 |
| Q2 2026 | Paul Tudor Jones narrow view | Closed | 0 | 0.03 |
| Q1 2026 | Paul Tudor Jones narrow view | Added 3.7% | 216,311 | 0.00 |
| Q4 2025 | Paul Tudor Jones narrow view | New | 208,639 | 0.03 |
Added: opened or increased
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Paul Tudor Jones narrow view | New | 131,221 | 0.02 |
| Q1 2026 | Paul Tudor Jones narrow view | Added 3.7% | 216,311 | 0.00 |
| Q4 2025 | Paul Tudor Jones narrow view | New | 208,639 | 0.03 |
Reduced: reduced or closed
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q2 2026 | Paul Tudor Jones narrow view | Closed | 0 | 0.03 |
History
1 peakQ3 2026: 1 tracked investors
20182026
Shares held, last 8 quarters
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Paul Tudor Jones | 131.2K | – | 216.3K | 208.6K | – | – | 53.5K | 43.0K |
– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).